ESH well overvalued, page-27

First 27 Last

Share
Profile

Follow
clogg

26 Posts.

4

18/04/18

14:49

Post #: 32529919
Share

Originally posted by wasko ↑

It's starting to feel like the Cold War in here! Suspicion, propaganda and counter-intelligence.

Here is what I would like to see from this company:
1.) A statement on whether the 300,000 registered customers on their platform are just the "re-activated" Razer Arena users (which they were entitled to re-target). If they have attracted completely new users then bravo to them, they are clearly doing something right in the marketing department.
2.) Figures on active users and also a definition of what an active user is e.g. logged in to platform or played in a tournament, 1+ times in the last week, month, year?
2.) A clear overview of their plan to generate revenue from registered users and a more detailed timeline, are they seriously launching everything in May 2018 at the same time? No more silly powerpoints about 'monetization innovations', nothing on that slide is an innovation.
3.) An answer to the question about whether they are the exclusive partner to Razer, or can other companies also license the Razer Arena software and "hey presto" instant competition. This is similar in my opinion to whether a company has a patented product or just a product.

Chances of getting the above are slim, although I would happily be proven wrong.

I am keeping my eyes on this company after previously selling out, can't see myself taking a position again until after the revenue initiatives are launched in May 2018 (see point 3 above) and we can mull over the results.

If anyone else is on the sidelines like me, happy to hear what would make you take another look at this company.

Expand

Hello Wasko, Have you tried to ask these questions direct?
Contact: Peter Nesvida Corporate Affairs & International Investor Relations eSports Mogul Asia Pacific Limited M: +61 412 357 375 E: [email protected]

ESH Price at posting: 1.7¢ Sentiment: Buy Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

AFP

AFT Pharmaceutical's multi-billion R&D opportunity

Expert Exchange: The Kouk on Michelle Bullock's legacy as RBA Governor

KLV

Klevo Rewards advances stablecoin strategy with credit licence acquisition

DBO

Diablo expands critical minerals footprint at Star Range

PL9

Prairie Lithium advances towards first production as commercial DLE unit arrives

First 27 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

ESH well overvalued, page-27

Top Stories

AFT Pharmaceutical's multi-billion R&D opportunity

Expert Exchange: The Kouk on Michelle Bullock's legacy as RBA Governor

Klevo Rewards advances stablecoin strategy with credit licence acquisition

Diablo expands critical minerals footprint at Star Range

Prairie Lithium advances towards first production as commercial DLE unit arrives

Featured News